Allstate (ALL) CEO Thomas J. Wilson granted 106,482 employee stock options

Rhea-AI Filing Summary

WILSON THOMAS J reported acquisition or exercise transactions in this Form 4 filing.

ALLSTATE CORP Chairman, President & CEO Thomas J. Wilson received an award of 106,482 employee stock options on February 19, 2026. These options give him the right to buy Allstate shares in the future as part of his compensation.

According to the award terms, the option becomes exercisable in three equal parts, with one third vesting on February 19, 2027, another third on February 19, 2028, and the final third on February 19, 2029, with any fractional shares rounded as provided in the award agreement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON THOMAS J

(Last) (First) (Middle)

C/O THE ALLSTATE CORPORATION

3100 SANDERS ROAD

(Street)

NORTHBROOK IL 60062-7154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLSTATE CORP [ ALL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$203.22	02/19/2026		A		106,482		(1)	02/19/2036	Common Stock	106,482	$0	106,482	D

Explanation of Responses:

1. Option exercisable in three increments, with one third vesting on February 19, 2027, February 19, 2028, and February 19, 2029, with any fractional shares to be rounded as provided for in award agreement.

	/s/ Thomas J. Wilson	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Allstate (ALL) report for Thomas J. Wilson?

Allstate reported that Chairman, President & CEO Thomas J. Wilson received a grant of 106,482 employee stock options on February 19, 2026. This award provides rights to purchase Allstate shares in the future, subject to a multi-year vesting schedule defined in the grant terms.

How many stock options were granted to the Allstate (ALL) CEO in this Form 4?

The Allstate CEO received 106,482 employee stock options in this reported grant. These options represent rights to acquire Allstate common shares over time, aligning executive compensation with shareholder value as the options vest and potentially become exercisable in future years.

What is the vesting schedule for Thomas J. Wilson’s Allstate (ALL) option grant?

The option vests in three equal installments: one third on February 19, 2027, one third on February 19, 2028, and the final third on February 19, 2029. Any fractional shares are rounded as specified in the related award agreement.

Is the Allstate (ALL) CEO’s Form 4 transaction a purchase or an award?

The transaction is classified as an award or other acquisition of derivative securities, not an open-market purchase. It reflects a grant of employee stock options as compensation, with the Form 4 using code “A” for a grant, award, or other acquisition.

Does this Allstate (ALL) Form 4 show any insider selling activity?

This Form 4 only reports an acquisition of derivative securities through a stock option grant to the CEO. The transaction summary indicates one acquisition event and no dispositions or sales, making it a compensatory award rather than a sale of existing shares.